Dexcel Pharma USA Launches Nintedanib Capsules After FDA Approval Dexcel Pharma USA has secured FDA approval for Nintedanib Capsules, a key treatment for Idiopathic Pulmonary Fibrosis. The launch marks an important step in expanding patient access to essential medications.

Dexcel Pharma USA Launches Nintedanib Capsules After FDA Approval #USA #Parsippany #Dexcel_Pharma #Nintedanib #OFEV

Dexcel Pharma USA Secures U.S. Rights to Zubsolv® Expanding Treatment Options Dexcel Pharma USA has announced the successful acquisition of U.S. rights for Zubsolv®, marking a significant step in their strategic growth in the U.S. market.

Dexcel Pharma USA Secures U.S. Rights to Zubsolv® Expanding Treatment Options #USA #Parsippany,_NJ #Dexcel_Pharma #Zubsolv #Orexo_AB